Plasma Donors Recognized For Their Lifesaving Contributions To The Treatment Of Rare Diseases

 Plasma Donors Recognized For Their Lifesaving Contributions To The Treatment
                               Of Rare Diseases

CSL Plasma and CSL Behring celebrate International Plasma Awareness Week with
week-long activities and an upcoming center opening in Alabama

PR Newswire

KING OF PRUSSIA, Pa., Oct. 15, 2013

KING OF PRUSSIA, Pa., Oct. 15, 2013 /PRNewswire/ --CSL Plasma, operator of
one of the largest plasma collection networks in the world and parent company
CSL Behring are celebrating the contributions of donor-heroes during
International Plasma Awareness Week (IPAW), October 13–20.The week-long
observance, which is sponsored by the Plasma Protein Therapeutics Association
and its member-companies, raises global awareness of source plasma collection
and increases understanding of plasma protein therapies and rare diseases.

(Logo: http://photos.prnewswire.com/prnh/20100914/PH63692LOGO)

The opening of the Montgomery, Ala. plasma center is the latest in CSL
Plasma's expansion of its collection network in the East region. The new
center reflects CSL Plasma and CSL Behring's commitment to meeting the
increasing global demand for plasma, and to providing quality therapies to the
rare disease community. CSL Plasma operates 82 plasma centers in the United
States and 8 in Germany.

CSL Plasma Senior Vice President and General Manager, Randy Furby, says,
"Plasma that is donated in the collection centers is used to make therapies
that replace missing or deficient proteins that cause rare diseases such as
hemophilia, primary immune deficiencies, hereditary angioedema and inherited
respiratory disease. We view our donors as heroes because without their
contributions, CSL Behring would not be able to provide the lifesaving and
quality of life-enhancing products that our patients rely on."

Pete Dyson coaches basketball at Pocono Mountain East High School in
Pennsylvania. He fell in love with the sport at an early age when his
grandfather took him to high school games. Pete is a hemophiliac who is
treated with one of CSL Behring's products. He is also a CSL Behring consumer
advocate. Pete says donors are special people, and that they are literally his
"lifeblood."

"People tend to try to limit what you're able to do when you have a bleeding
disorder because they want to protect you. They don't always understand that
what you want most is to live a normal life. Because of plasma donors, I'm
able to live a normal life. It's incredibly liberating. Without the plasma
they're willing to give, my life would be very different, like living in a
bubble. I can't thank plasma donors enough."

CSL Plasma is holding a variety of activities in its centers nationwide during
IPAW to promote greater understanding and appreciation among patients,
employees and donors.CSL Plasma staff is personally thanking donors in the
centers for their time, and emphasizing the impact their donations have on
patients' lives.Other activities focus on educating community and civic
leaders about donors and the economic impact of a plasma center on the
community. CSL Plasma centers on average infuse between $5 and $6 million
directly into the local economy in wages and donor compensation.

About CSL Behring
CSL Behring is a leader in the plasma protein therapeutics industry. Committed
to saving lives and improving the quality of life for people with rare and
serious diseases, the company manufactures and markets a range of
plasma-derived and recombinant therapies worldwide.

CSL Behring therapies are used around the world to treat coagulation disorders
including hemophilia and von Willebrand disease, primary immune deficiencies,
hereditary angioedema and inherited respiratory disease, and neurological
disorders in certain markets. The company's products are also used in cardiac
surgery, organ transplantation, burn treatment and to prevent hemolytic
diseases in the newborn.

CSL Behring operates one of the world's largest plasma collection networks,
CSL Plasma. CSL Behring is a global biopharmaceutical company and a member of
the CSL Group of companies. The parent company, CSL Limited (ASX:CSL), is
headquartered in Melbourne, Australia. For more information, visit
http://www.cslbehring.com/.

Contact:
Chris Florentz                      Scott Newkirk
CSL Behring                         CSL Plasma
610-878-4316                         561-912-3085
Christopher.Florentz@cslbehring.com Patrick.Newkirk@cslplasma.com

SOURCE CSL Plasma

Website: http://www.cslbehring.com